Glycosylation pathway stimulation

Glycosylation pathway stimulation refers to enhanced activity of the cellular processes that add glycans to proteins and lipids, primarily in the endoplasmic reticulum and Golgi apparatus. Glycosylation is essential for protein folding, stability, cellular signaling, immune responses, and cell adhesion, and is mediated by a broad family of glycosyltransferases and glycosidases[1][2][5][10]. Stimulation or dysregulation of glycosylation pathways affects diverse biological processes and is implicated in diseases such as cancer (where aberrant glycosylation increases metastasis and drug resistance), congenital disorders (deficiency or alteration in glycan biosynthesis), autoimmunity (altered glycosylation of immunoglobulins or receptors), and neurodegeneration[9][1]. Glycosylation pathway stimulation is not a single drug target but describes cellular pathway modulation, and it is not accurately classified as a receptor, enzyme, transporter, or similar target class.

Other names

GlycosylationGlycosylation pathwayProtein glycosylation